Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Propionate for Facial Allergy Symptoms in Seasonal Allergic Rhinitis
NCT07817134Phase 4Not yet recruiting
- Sponsor
- Haleon
- Start
- Sep 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone propionate nasal spray in seasonal allergic rhinitis (SAR), sponsored by Haleon. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT07817134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07817134.